SIME Diagnostics Limited is a London‑based clinical AI and med‑tech company that develops and provid Sign up to read more
| Allotment | Filed | Share Class | Round Size | Round Type |
|---|---|---|---|---|
2026-02-26 | £97k |
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| MARTIN COLLINS | ORDINARY | 385,581 | 16.3% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 888888888888888888 | 8888888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
77 more shareholders on file , sign up free to see.
Companies with the most similar business descriptions.
Capital raised per employee divides the equity SIME DIAGNOSTICS LIMITED raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
A share class is a category of shares carrying its own rights over voting, dividends and what happens to the money if the company is sold or wound up. UK companies typically issue Ordinary shares to founders and employees, then create a new Preferred class at each funding round, giving investors priority on proceeds ahead of the Ordinary holders. SIME DIAGNOSTICS LIMITED has 5 distinct classes on file at Companies House; the rights attached to each are reproduced below as filed.
A ORDINARY SHARES HAVE THE RIGHT TO VOTE. A ORDINARY SHARES HAVE THE RIGHT TO RECEIVE DIVIDENDS. ON A RETURN OF ASSETS ON LIQUIDATION, CAPITAL REDUCTION OR OTHERWISE (INCLUDING SALE) THE A ORDINARY SHARES HAVE TH E FIRST PREFERENTIAL RIGHT TO RECEIVE IN RESPECT OF EACH A ORDINARY SHARE. THE INITIAL SUBSCRIPTION PRICE OF THAT A ORDINARY SHARE. TOGETHER WITH A SUM EQUAL TO ANY ARREARS AND ACCRUALS OF ANY DIVIDEND IN RESPECT OF THAT A ORDINARY SHARE CALCULATED DOWN TO (AND INCLUDING) THE DATE OF THE RETURN OF CAPITAL. A ORDINARY SHARES ARE NOT REDEEMABLE.
B ORDINARY SHARES HAVE THE RIGHT TO VOTE. B ORDINARY SHARES HAVE THE RIGHT TO RECEIVE DIVIDENDS. ON A RETURN OF ASSETS ON LIQUIDATION, CAPITAL REDUCTION OR OTHERWISE (INCLUDING SALE), THE B ORDINARY SHARES PARTICIPATE ON A PARI PASSU BASIS WITH THE A ORDINARY, ORDINARY AND PREFERRED ORDINARY SHARES AFTER THE PREFERENTIAL RIGHTS OF THE A ORDINARY AND PREFERRED ORDINARY SHARES REFERRED TO HAVE BEEN SATISFIED. B ORDINARY SHARES ARE NOT REDEEMABLE
ORDINARY SHARES HAVE THE RIGHT TO VOTE. ORDINARY SHARES HAVE THE RIGHT TO RECEIVE DIVIDENDS. ON A RETURN OF ASSETS ON LIQUIDATION, CAPITAL REDUCTION OR OTHERWISE (INCLUDING SALE), THE ORDINARY SHARES PARTICIPATE ON A PARI PASSU
PREFERRED ORDINARY SHARES HAVE NO RIGHT TO VOTE IN ANY CIRCUMSTANCES. PREFERRED ORDINARY SHARES HAVE THE RIGHT TO RECEIVE DIVIDENDS. ON A RETURN OF ASSETS ON LIQUIDATION, CAPITAL REDUCTION OR OTHERWISE (INCLUDING SALE) THE PREFERRED ORDINARY SHARES HAVE A PREFERENTIAL RIGHT TO RECEIVE IN RESPECT OF EACH PREFERRED ORDINARY SHARE, THE INITIAL SUBSCRIPTION PRICE OF THAT PREFERRED ORDINARY SHARE, TOGETHER WITH A SUM EQUAL TO ANY ARREARS AND ACCRUALS OF ANY DIVIDEND IN RESPECT OF THAT PREFERRED ORDINARY SHARE CALCULATED DOWN TO (AND INCLUDING) THE DATE OF THE RETURN OF CAPITAL. PREFERRED ORDINARY SHARES ARE NOT REDEEMABLE.
PREFERRED ORDINARY SHARES HAVE NO RIGHT TO VOTE IN ANY CIRCUMSTANCES. PREFERRED ORDINARY SHARES HAVE THE RIGHT TO RECEIVE DIVIDENDS. ON A RETURN OF ASSETS ON LIQUIDATION, CAPITAL REDUCTION OR OTHERWISE (INCLUDING SALE) THE PREFERRED ORDINARY SHARES HAVE A PREFERENTIAL RIGHT TO RECEIVE IN
These are the directors and secretaries who have left SIME DIAGNOSTICS LIMITED. A resignation is filed with Companies House on form TM01 and the date below is the date the officer's appointment ended, not the date it was filed. Departures matter for reading a company's history: a founder leaving shortly after a funding round, or several directors resigning at once, is often the visible trace of a change of control or a restructure.